A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system. The virus causes infected cells to release decoys that inactivate neutralizing antibodies and prevent immune cells from releasing important messenger molecules. These findings could lead to the development of […]Continue Reading ...
The Lancet has reported about the alarming status of Ebola in the Democratic Republic of Congo (DRC) on the 4th of this month following a reported 785 deaths due to the disease in the country. Ebola Virus illustration. Image Credit: Festa / Shutterstock The DRC has reported 22 new cases to add to the outbreak. […]Continue Reading ...
“It’s an incomplete study, a work in progress,” said Simon J. Anthony, a virologist at Columbia University.Continue Reading ...
AHF urges the United Nations to follow its existing mandate for the Democratic Republic of the Congo to ensure Ebola-relief efforts can proceed without the threat of violence against healthcare workers, resources and civilians. As the second worst Ebola outbreak in history rages on in Central Sub-Saharan Africa, AIDS Healthcare Foundation (AHF) urges the United […]Continue Reading ...
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies (mAbs) that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe. The mAb “cocktail,” called MBP134, is the first experimental treatment to […]Continue Reading ...
NEIDL researcher Robert Davey has found that derivatives from a commonly used anti-malarial can prevent Ebola virus from entering cells. Credit: Cydney Scott, Boston University Photography. Robert Davey, professor of microbiology at Boston University School of Medicine and researcher at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), in collaboration with researchers at Nagasaki University, […]Continue Reading ...
With the world’s second worst Ebola outbreak in history recently spreading to a major city in the Democratic Republic of the Congo, the World Health Organization (WHO) and Merck must do more to ensure all options are on the table to fight the virus, including ensuring vaccines are available to all who need them. Although […]Continue Reading ...
Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus). This is the second Ebola rapid antigen fingerstick test available under EUA, but the first that uses a portable battery-operated reader, which can help provide […]Continue Reading ...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children’s Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Cincinnati Children’s is one of nine […]Continue Reading ...
The government of Liberia, in partnership with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and EcoHealth Alliance, announced the discovery of Ebola virus in a bat in Liberia. This is the first finding of Zaire ebolavirus in a bat in West Africa, adding to other evidence […]Continue Reading ...
There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host & Microbe. Dr. Thomas Geisbert, a world-renowned Ebola researcher at The University of Texas Medical Branch, said that previous therapeutics typically were […]Continue Reading ...
Ebola virus particles (red) on a larger cell. Credit: NIAID No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that. Scientists identified […]Continue Reading ...
A female baby was diagnosed with the deadly Ebola when she was only six days old. According to the health officials in the Democratic Republic of the Congo (DRC), she seemed to have miraculously recovered from the viral infection. Ebola virus seen under a microscope. Image Credit: Studio_3321 / Shutterstock The baby named Benedicte was […]Continue Reading ...
Drug that mimics function of protein could one day become an effective therapy to fight Ebola virus Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new Northwestern Medicine study. The newly discovered ability of the […]Continue Reading ...
Healthcare workers in Uganda have begun vaccinating high risk health workers against the deadly viral infection Ebola this week. This is the first time that a vaccination drive has begun before the actual outbreak. This precaution is being taken because the health care officials are worried that the infection would spread into the country from […]Continue Reading ...
- FDA authorizes new interoperable insulin pump for children, adults with diabetes
- Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
- Skin Cancer Screening: MedlinePlus Lab Test Information
- ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
- Cell manipulation could soon halt or reverse aging
- Pumped Breast Milk Falls Short of Breastfed Version
- Men’s porn habits could fuel partners’ eating disorders, study suggests
- Rapid progression of age-related diseases may result from formation of vicious cycles
- Immune checkpoint molecule protects against future development of cancer
- New method produces hydrogels that have properties similar to cells’ environment
- $4.1 million funding for heart research on Valentine’s Day
- General anesthesia in early infancy unlikely to have lasting effects on developing brains
- New breakthroughs for muscular dystrophy research
- First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
- Vapers develop cancer-related gene deregulation as cigarette smokers
- Bringing Antimicrobial Susceptibility Testing (AST) to the Community
- Decolonization protocol after hospital discharge can prevent dangerous infections
- Therapeutic endoscopy has an expanding role in the treatment of IBD
- Blood clot discovery could lead to development of better treatments for blood diseases
- Intervention can increase exclusive breastfeeding rates